ICCS 2026 Symposium

The Shift to Animal-free Safety Assessment is no Longer Theoretical

On June 15, ICCS convened a half-day symposium dedicated to advancing the global transition to animal-free assessments. More than 125 leaders from industry, regulatory agencies, and NGOs will gather in Brussels for “a fully subscribed” event focused on accelerating progress and impact.

Together, participants will explore implementation pathways, capacity-building priorities, and emerging science that can help shape the future of animal-free innovation.

Watch the Sessions on Demand

We recorded the sessions which are now available on demand. See it again or watch it for the first time.

Watch Now

Opening: Stéphane Dhalluin, PhD, DABT, Board Chair

"When ICCS was founded several years ago, it was built on the belief that meaningful progress in safety assessment would require more than scientific innovation alone. It would require dialogue, partnership, and a willingness to work across traditional boundaries."
— Stéphane Dhalluin, PhD, DABT, ICCS Board Chair

Sessions and Speakers

From Vision to Reality: Implementing the EU Roadmap Together

Georg Streck PhD, Policy Officer, REACH Unit, DG GROW, European Commission
Katia Lacasse, PhD, Senior Advisor, Product Stewardship, CEFIC, European Chemical Industry Council
Gavin Maxwell, PhD, Head of Regulatory Science Strategy and Advocacy, Unilever
Julia Baines, PhD, Head of Science Policy, PETA UK
Matthias Herzler, PhD, Head of Unit Coordination and Assessment Strategies, BfR, German Federal Institute for Risk Assessment
Moderator: Claire Fletcher, Director, Strategic Program Development, ICCS

Identifying and Addressing Capacity Needs for NAMs Implementation

Nicolas Fabre, PhD, Head of Chemical & Cosmetic Advocacy Expert Group - Scientific and Regulatory International Affairs, L’Oréal
Kristie Sullivan, MPH, Vice President Education and Outreach, Institute for In Vitro Sciences
Francesca Rapolla, MS, Senior Affairs Manager, Cosmetic, Toiletry and Perfumery Association (CTPA)
Beta Montemayor, Vice President and Director Science, Regulation and Market Access, Cosmetics Alliance Canada
Moderator: John Chave, Director General, Cosmetics Europe

Activity vs Adversity: The Quest to Solve the Endocrine Disruption Challenge Without Animals

Susanne Kolle, PhD, ERT, Research Coordinator, BASF SE
Karma Fussell, PhD, DABT, Senior Principal Toxicologist, Wella Company
Carol Courage, PhD, Global Head of Product Safety, Croda

ICCS Program Highlights

Andreas Schepky, PhD, Head Department of Global Toxicology, Beiersdorf
Véronique Poulsen, PhD, Director of Environmental Safety, L’Oréal
Beta Montemayor, Vice President and Director Science, Regulation and Market Access, Cosmetics Alliance Canada